Transcriptomics

Dataset Information

0

Treatment of MCF-7 cells with TRAIL and Smac mimetic (LCL-161)

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE122980 | GEO | 2021/02/24

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Treatment of MCF-7 cells with TRAIL and Smac mimetic (LCL-161) [seq]
2021-02-24 | GSE122979 | GEO
Transcriptomics Treatment of MCF-7 cells with TRAIL and Smac mimetic (LCL-161) [array]
2022-06-30 | GSE122307 | GEO
Unknown The SMAC mimetic LCL-161 selectively targets JAK2V617F mutant cells.
| S-EPMC6941266 | biostudies-literature
Genomics Treatment of MCF-7 cells with TRAIL and Smac mimetic (LCL-161)
| PRJNA507104 | ENA
Genomics Treatment of MCF-7 cells with TRAIL and Smac mimetic (LCL-161) [array]
| PRJNA504559 | ENA
Genomics Treatment of MCF-7 cells with TRAIL and Smac mimetic (LCL-161) [seq]
| PRJNA507110 | ENA
Unknown The SMAC mimetic LCL-161 displays antitumor activity in preclinical models of rituximab-resistant B-cell lymphoma.
| S-EPMC6290104 | biostudies-literature
Unknown The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.
| S-EPMC4848837 | biostudies-other
Unknown Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
| S-EPMC3230293 | biostudies-literature
Unknown Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.
| S-EPMC3091962 | biostudies-literature